Doç. Dr. Egemen Cebeci
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Glomerulonephritis, IGA 5 publicationsSource: OpenAlex / PubMed MeSHView publications
- Glomerulonephritis 4 publications
- Proteinuria 4 publications
- Kidney Failure, Chronic 3 publications
- COVID-19 3 publications
- Polycystic Kidney, Autosomal Dominant 3 publications
- Anemia 2 publications
- Kidney Diseases 2 publications
- Obesity 2 publications
- Glomerulonephritis, Membranous 2 publications
- Glomerulosclerosis, Focal Segmental 2 publications
- Albuminuria 2 publications
- Diabetes Mellitus, Type 2 2 publications
- Insulin Resistance 2 publications
- Hypothyroidism 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyNephrologysaglik.gov.trFrom source
- Institutionİstanbul Haseki Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
- Area of workGlomerulonephritis, IGAExtracted from 5 publications · Model version —From source
- Publications149 publicationsORCID, OpenAlexFrom source
- ORCID0000-0002-7393-5144ORCIDFrom source
- Last synchronised5 November 2026 08:56https://hasekieah.saglik.gov.tr/TR-671864/doktorlar.html#egemen-cebecisaglik.gov.tr
Scientific work
Publications on Glomerulonephritis, IGA
-
Interstitial Fibrosis Severity Is Not Independently Associated with Anemia in Biopsy-Proven Primary Glomerulonephritis: A Nationwide Registry Analysis
Medicina, 2026
DOI 10.3390/medicina62050820 PMID 42195073 Open-access full textSource: ORCID
-
Post-COVID-19 Outcomes of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Controlled Study
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15051850 PMID 41827265 Open-access full textSource: ORCID
-
Comparative Longitudinal Evaluation of Systemic Inflammatory Markers in Type 2 Diabetes Treated with Four Oral Antidiabetic Drug Classes
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15020688 PMID 41598626 Open-access full textSource: ORCID
-
Diagnostic Performance of Plasma Levels of sST2 (Soluble Suppression of Tumorigenicity 2) in the Evaluation of Hypervolemia in Hemodialysis Patients: A Comparative Analysis With Traditional and Alternative Biomarkers
Hemodialysis International, 2026
DOI 10.1111/hdi.70092 PMID 42173668 Source: OpenAlex
-
Therapeutic Plasma Exchange Using Membrane Plasma Separation Across a Broad Spectrum of Indications: An Eight-Year Single-Center Retrospective Cohort Study
International Journal of General Medicine, 2026
DOI 10.2147/ijgm.s625354 PMID 42670524 Open-access full textSource: ORCID
-
Determinants of anemia in patients with primary glomerulonephritis: a biopsy-based analysis
Acta Clinica Belgica, 2026
DOI 10.1080/17843286.2025.2605691 PMID 41442509 1 citation (Europe PMC) Source: ORCID
-
Evaluation of Long-Term Kidney Functions of Patients Developing Hospital-Associated Acute Kidney Injury During COVID-19 Infection
Turkish Journal of Nephrology, 2026
DOI 10.5152/turkjnephrol.2026.251197 Open-access full textSource: ORCID
-
Clinicopathologic features and outcomes of patients with DNAJB9-positive fibrillary glomerulonephritis
Clinical Kidney Journal, 2026
DOI 10.1093/ckj/sfag138 PMID 42311905 Open-access full textSource: ORCID
-
The Relationship Between Monocyte/High-Density Lipoprotein Cholesterol Ratio and Microvascular Complications in Patients with Type 2 Diabetes Mellitus
Kafkas Journal of Medical Sciences, 2026
DOI 10.5505/kjms.2026.76429 Open-access full textSource: OpenAlex
-
The Relationship of Bioimpedance and Biochemical Data with the Blood Pressure Response to Exercise
İç Hastalıkları Dergisi, 2025
DOI 10.5578/ichastaliklari.2025014 Open-access full textSource: OpenAlex